Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
ConclusionIn conclusion, we found no difference in the prevalence ofBRCA1 andBRCA2 founder mutations between cases and healthy controls. The mutationsBRCA1 andBRCA2 seem not to play a role in bladder and kidney cancer development in Polish patients.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Genetics | Kidney Cancer | Poland Health | Urology & Nephrology